| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |